BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 8190100)

  • 1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
    Berg KA; Clarke WP; Chen Y; Ebersole BJ; McKay RD; Maayani S
    Mol Pharmacol; 1994 May; 45(5):826-36. PubMed ID: 8190100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
    Debernardi MA; Munshi R; Brooker G
    Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5-hydroxytryptamine-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal smooth muscle cells by phorbol ester.
    Yang CM; Fen LW; Tsao HL; Chiu CT
    Br J Pharmacol; 1997 Jul; 121(5):853-60. PubMed ID: 9222540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
    Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
    Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
    Bian JS; Zhang WM; Pei JM; Wong TM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
    Quinn JC; Johnson-Farley NN; Yoon J; Cowen DS
    J Pharmacol Exp Ther; 2002 Nov; 303(2):746-52. PubMed ID: 12388661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C.
    Ren J; Karpinski E; Benishin CG
    J Pharmacol Exp Ther; 1996 Apr; 277(1):394-402. PubMed ID: 8613946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
    Lembo PM; Albert PR
    Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C is involved in cyclic adenosine monophosphate formation due to PGF2 alpha desensitization in bovine iris sphincter.
    Tachado SD; Zhang Y; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2023-32. PubMed ID: 8387977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protein kinase C in the regulation of prostaglandin synthesis in human endothelium.
    Garcia JG; Stasek J; Natarajan V; Patterson CE; Dominguez J
    Am J Respir Cell Mol Biol; 1992 Mar; 6(3):315-25. PubMed ID: 1540395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive regulation of phospholipase C responses by cAMP and calcium.
    Schachter JB; Ivins JK; Pittman RN; Wolfe BB
    Mol Pharmacol; 1992 Mar; 41(3):577-86. PubMed ID: 1312217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
    Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD
    Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
    Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium.
    Lin WW; Chuang DM
    Mol Pharmacol; 1993 Jul; 44(1):158-65. PubMed ID: 8341270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells.
    Yang CM; Yo YL; Hsieh JT; Ong R
    Br J Pharmacol; 1994 Mar; 111(3):777-86. PubMed ID: 8019756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1997 Aug; 121(8):1749-57. PubMed ID: 9283713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
    Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
    Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced activation of phospholipase D in bovine pulmonary artery endothelial cells: regulation by protein kinase C and calcium.
    Natarajan V; Garcia JG
    J Lab Clin Med; 1993 Feb; 121(2):337-47. PubMed ID: 8433044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular cAMP and calcium signaling by serotonin in mouse cumulus-oocyte complexes.
    Amireault P; Dubé F
    Mol Pharmacol; 2005 Dec; 68(6):1678-87. PubMed ID: 16131615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.